BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 38550195)

  • 1. One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents.
    Moshkowitz M; Reif S; Brill S; Ringel Y; Arber N; Halpern Z; Bujanover Y
    Pediatrics; 1998 Jul; 102(1):e14. PubMed ID: 9651466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
    Moshkowitz M; Konikoff FM; Peled Y; Brill S; Hallak A; Tiomny E; Santo M; Bujanover Y; Gilat T
    Aliment Pharmacol Ther; 1996 Dec; 10(6):1015-9. PubMed ID: 8971304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
    Cammarota G; Cannizzaro O; Tursi A; Papa A; Gasbarrini A; Cuoco L; Cianei R; Armuzzi A; Fedeli P; Fedeli G; Gasbarrini G
    Aliment Pharmacol Ther; 1998 Jun; 12(6):539-43. PubMed ID: 9678813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
    He C; Kong F; Zhu X; Kong F; Zhao W; Liu Y; Wang K
    Biomed Res Int; 2021; 2021():4171019. PubMed ID: 34888378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
    International BR
    Biomed Res Int; 2024; 2024():9783981. PubMed ID: 38550195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of H. pylori infection.
    Bazzoli F; Pozzato P
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():39-46. PubMed ID: 9440054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
    Gut; 1997 Jul; 41(1):8-13. PubMed ID: 9274464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarithromycin for treatment of Helicobacter pylori infections.
    Graham DY
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S55-8. PubMed ID: 8574737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Helicobacter pylori therapy with omeprazole and clarithromycin: current status].
    Labenz J
    Leber Magen Darm; 1994 Sep; 24(5):203-9. PubMed ID: 7968179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Helicobacter pylori--overview of therapy].
    Katicić M; Prskalo M; Tićak M; Sabarić B; Marusić M; Banić M; Buljevac M; Kujundzić M; Jelić D; Kozić M; Mihaljević S; Mićunović Z; Skurla B; Filipec T
    Lijec Vjesn; 2002 Sep; 124 Suppl 1():72-8. PubMed ID: 12592823
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.